NCT03472521View on ClinicalTrials.gov

Prevention of Persistent Opioid Use in Mothers

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

September 17, 2018

Primary Completion Date

July 2, 2020

Study Completion Date

April 10, 2021

Conditions
Opioid UsePostpartum DisorderChronic Pain Syndrome
Interventions
DRUG

Gabapentin

Treatment with analgesic adjutant commonly used for post-operative pain, titrated to effect by chronic pain specialist compared to placebo titration.

DRUG

Placebo

Placebo to match gabapentin

Trial Locations (1)

94305

Lucille Packard Children's Hospital, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT03472521 - Prevention of Persistent Opioid Use in Mothers | Biotech Hunter | Biotech Hunter